Craig Adam R — SEC Form 4 filings

SEC reporting owner CIK 1339498. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-13.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-08-14 to 2026-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
X4 Pharmaceuticals, Inc (XFOR)Executive Chairman, Director41 leg · 86,206 sh · $249,9971 leg · 47,436 sh · $210,8294

Form 4 filings — Craig Adam R

FiledFormIssuerReported transactionsSource
2026-08-134X4 Pharmaceuticals, Inc (XFOR)Sale (S): 47,436 @ $4.44EDGAR
2025-10-314X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 2,329,154 (derivative) @ $0EDGAR
2025-10-274X4 Pharmaceuticals, Inc (XFOR)Purchase (P): 86,206 @ $2.90EDGAR
2025-08-144X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 289,881 @ $0 · Grant/award (A): 1,609,873 (derivative) @ $0 · Grant/award (A): 529,201 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1339498 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →